177 related articles for article (PubMed ID: 35884555)
21. Relationship between cachexia and perineural invasion in pancreatic adenocarcinoma.
Petrusel L; Rusu I; Leucuta DC; Seicean R; Suharoschi R; Zamfir P; Seicean A
World J Gastrointest Oncol; 2019 Dec; 11(12):1126-1140. PubMed ID: 31908718
[TBL] [Abstract][Full Text] [Related]
22. CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.
Krieg A; Riemer JC; Telan LA; Gabbert HE; Knoefel WT
PLoS One; 2015; 10(6):e0130192. PubMed ID: 26091099
[TBL] [Abstract][Full Text] [Related]
23. CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration.
Zhang R; Liu Q; Peng J; Wang M; Li T; Liu J; Cui M; Zhang X; Gao X; Liao Q; Zhao Y
J Cancer; 2020; 11(9):2371-2381. PubMed ID: 32201508
[No Abstract] [Full Text] [Related]
24. Tumor budding as a prognostic factor in pancreatic ductal adenocarcinoma.
Petrova E; Zielinski V; Bolm L; Schreiber C; Knief J; Thorns C; Bronsert P; Timme-Bronsert S; Bausch D; Perner S; Keck T; Wellner U
Virchows Arch; 2020 Apr; 476(4):561-568. PubMed ID: 31786688
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of para-aortic lymph node status in resected pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous neoplasm - Time to consider a reclassification?
Linder S; Holmberg M; Engstrand J; Ghorbani P; Sparrelid E
Surg Oncol; 2022 May; 41():101735. PubMed ID: 35287096
[TBL] [Abstract][Full Text] [Related]
26. Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells.
Momeny M; Alishahi Z; Eyvani H; Esmaeili F; Zaghal A; Ghaffari P; Tavakkoly-Bazzaz J; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
Cell Oncol (Dordr); 2020 Feb; 43(1):81-93. PubMed ID: 31512195
[TBL] [Abstract][Full Text] [Related]
27. Low expression of DDX5 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma.
Morimachi M; Hirabayashi K; Takanashi Y; Kawanishi A; Saika T; Ueyama Y; Nakagohri T; Nakamura N; Suzuki H; Kagawa T
J Clin Pathol; 2021 Nov; 74(11):741-745. PubMed ID: 33097588
[TBL] [Abstract][Full Text] [Related]
28. The prognostic significance of clinicopathological features and apoptosis inhibitor proteins in pancreas ductal adenocarcinoma.
Argon A; Nart D; Oruç N; Coker A; Ozütemiz O
Acta Gastroenterol Belg; 2014 Jun; 77(2):229-34. PubMed ID: 25090821
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
Sun B; Liu X; Gao Y; Li L; Dong Z
Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430
[TBL] [Abstract][Full Text] [Related]
30. The clinical significance of FRAT1 and ABCG2 expression in pancreatic ductal adenocarcinoma.
Yuan Y; Yang Z; Miao X; Li D; Liu Z; Zou Q
Tumour Biol; 2015 Dec; 36(12):9961-8. PubMed ID: 26178481
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
[TBL] [Abstract][Full Text] [Related]
32. Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Fermér C; Nilsson O; Seppänen H; Haglund C
PLoS One; 2015; 10(6):e0129012. PubMed ID: 26053486
[TBL] [Abstract][Full Text] [Related]
33. The combination of strong immunohistochemical mtTFA expression and a high survivin index predicts a shorter disease-specific survival in pancreatic ductal adenocarcinoma.
Kimura T; Kitada S; Uramoto H; Zhi L; Kawatsu Y; Takeda T; Horie S; Nabeshima A; Noguchi H; Sasaguri Y; Izumi H; Kohno K; Yamada S
Histol Histopathol; 2015 Feb; 30(2):193-204. PubMed ID: 25108120
[TBL] [Abstract][Full Text] [Related]
34. Elevated expression of CTHRC1 predicts unfavorable prognosis in patients with pancreatic ductal adenocarcinoma.
Liu W; Fu XL; Yang JY; Yang MW; Tao LY; Liu DJ; Huo YM; Zhang JF; Hua R; Sun YW
Am J Cancer Res; 2016; 6(8):1820-7. PubMed ID: 27648368
[TBL] [Abstract][Full Text] [Related]
35. Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer.
Rexhepaj E; Jirstrom K; O'Connor DP; O'Brien SL; Landberg G; Duffy MJ; Brennan DJ; Gallagher WM
BMC Cancer; 2010 Nov; 10():639. PubMed ID: 21092276
[TBL] [Abstract][Full Text] [Related]
36. Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma.
Alhasan SF; Haugk B; Ogle LF; Beale GS; Long A; Burt AD; Tiniakos D; Televantou D; Coxon F; Newell DR; Charnley R; Reeves HL
Br J Cancer; 2016 Sep; 115(7):797-804. PubMed ID: 27560551
[TBL] [Abstract][Full Text] [Related]
37. EGFR, but not COX-2, protein in resected pancreatic ductal adenocarcinoma is associated with poor survival.
Fagman JB; Ljungman D; Falk P; Iresjö BM; Engström C; Naredi P; Lundholm K
Oncol Lett; 2019 Jun; 17(6):5361-5368. PubMed ID: 31186753
[TBL] [Abstract][Full Text] [Related]
38. High Annexin A10 expression is correlated with poor prognosis in pancreatic ductal adenocarcinoma.
Ishikawa A; Kuraoka K; Zaitsu J; Saito A; Yamaguchi A; Kuwai T; Sudo T; Hadano N; Tashiro H; Taniyama K; Yasuif W
Histol Histopathol; 2022 Mar; 37(3):243-250. PubMed ID: 34821375
[TBL] [Abstract][Full Text] [Related]
39. Survivin expression as an independent predictor of overall survival in pancreatic adenocarcinoma.
Contis J; Lykoudis PM; Goula K; Karandrea D; Kondi-Pafiti A
J Cancer Res Ther; 2018 Sep; 14(Supplement):S719-S723. PubMed ID: 30249893
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of
Ecke TH; Kiani A; Schlomm T; Friedersdorff F; Rabien A; Jung K; Kilic E; Boström P; Tervahartiala M; Taimen P; Gleichenhagen J; Johnen G; Brüning T; Koch S; Roggisch J; Wirtz RM
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
